Navigation Links
FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
Date:3/23/2009

New Indication is One of Three FDA Approvals Spanning Lilly Neuroscience Brands

INDIANAPOLIS, March 23 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration (FDA) has approved a new indication for Symbyax(R) (olanzapine and fluoxetine HCl capsules), Eli Lilly and Company (NYSE: LLY) announced today. Symbyax is now the first drug approved by the FDA for the acute treatment of treatment-resistant depression (TRD).

"Living with major depressive disorder is difficult and distressing for anyone, but even more so for patients whose symptoms continue despite treatment," said Lilly Medical Director Dr. Sara Corya. "Until today, there has been no approved medication for treatment-resistant depression. Now, after two failed attempts with other antidepressants, doctors and patients have a new treatment option."

In other actions, the FDA approved two new combination indications for Zyprexa(R) (olanzapine) and fluoxetine for the acute treatment of bipolar depression and TRD. Lilly originally developed Prozac(R) (fluoxetine HCl), the branded version of fluoxetine.

Additionally, the format of the product labels was updated according to the Physician's Labeling Rule (PLR), which many consider easier to understand. Additions were also made to the Medication Guides for Symbyax and Prozac, and a new Medication Guide was created for Zyprexa. Medication Guides include information for patients about potential risks associated with a particular product.

"Lilly maintains its commitment to patients by the continued research of Zyprexa, Symbyax, and Prozac," said Dr. Cherri Miner, Lilly neuroscience senior medical director. "Today's new indications confirm that these medications are valuable tools for patients in the fight against severe and disabling mental illness, and expan
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. FDA Approves New Roche West Nile Virus Blood Screening Test
3. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. FDA Approves SOMA(R) (carisoprodol) 250 mg
6. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
7. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. ABIH Approves Certification Credit for SSPC Training Courses
10. FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
11. FDA Approves New Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Ticket Down announces that Ed Sheeran ... months of 2015. Tickets for his tour have been ... a record pace. , Ed Sheeran 2015 Tour ... Center, Wednesday, May 6, 2015 , 5/7/15, Ed Sheeran Tickets, ... 7, 2015 , 5/9/15, Ed Sheeran Tickets, Tulsa, OK BOK ...
(Date:2/27/2015)... New York, NY (PRWEB) February 27, 2015 ... announces Google Field Trip Days at MoMath, a new collaboration ... trips to the only math museum in North America on ... nearly 400 students in grades 6-8 from seven schools in ... of hands-on activities and learning. , MoMath strives to fulfill ...
(Date:2/27/2015)... 2015 On time and under budget, ... Hospital Joplin. Inside and out, the nearly 900,000-square-foot facility ... to replace the tornado-ravaged St. John’s Regional Medical Center ... is opening just 46 months after the tornado hit ... normally anticipate to plan, design and construct a similarly ...
(Date:2/27/2015)... FL (PRWEB) February 27, 2015 Local lice ... the rise, particularly in the areas of Pinecrest, Key Biscayne, ... frantic and frustrated as they attempt to isolate and eradicate ... that the common “selfie” photograph may be partly to blame. ... create the kind of head-to-head contact that can allow for ...
(Date:2/27/2015)... Burien Nursing and Rehabilitation Center was ... with the Facility of the Year award. This award ... quality of care / satisfaction, census development, employee satisfaction ... to attend the awards banquet held in Dana Point, ... receive this award on behalf of our team at ...
Breaking Medicine News(10 mins):Health News:Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale 2Health News:Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale 3Health News:Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale 4Health News:National Museum of Mathematics and Google Collaborate to Offer Cost-Free Field Trip Days for Title I Schools in NYC 2Health News:National Museum of Mathematics and Google Collaborate to Offer Cost-Free Field Trip Days for Title I Schools in NYC 3Health News:New Hospital Built to Stand Against Nature 2Health News:New Hospital Built to Stand Against Nature 3Health News:New Hospital Built to Stand Against Nature 4Health News:Parents frustrated as selfies continue to contribute to the spread of head lice in Miami according to the largest Lice Removal Service in Miami called Lice Troopers 2Health News:Burien Nursing and Rehabilitation Center Receives Top Honors with Facility of the Year Award 2Health News:Burien Nursing and Rehabilitation Center Receives Top Honors with Facility of the Year Award 3
... from the University of Alabama at Birmingham (UAB) ... common anti-HIV drugs can prevent HIV-positive pregnant women ... drugs, potentially improving future treatment options., Providing tenofovir ... the extent of resistance to non-nucleoside reverse transcriptate ...
... footwear works best , , FRIDAY, Nov. 9 (HealthDay News) -- ... flexible walking shoes than with other types of footwear, ... the better for the knees, the study finds. , "The ... affects your feet but can affect other joints at your ...
... Girls on the Run-Chicago, CHICAGO, Nov. 9 Get ... more with all the auction items offered for,sale at this ... the,Chicago Cultural Center. The annual event, which attracts more than ... cocktails, hors d,oeuvres and plenty of fun--all for a great ...
... Babies driving robots.,It sounds like the theme ... the focus,of important and innovative research being conducted ... repercussions for the cognitive,development of infants with special ... (Cole) Galloway, associate professor of,physical therapy, and Sunil ...
... As part of the Company,s,commitment to encourage ... support today for the amendment to the Farm ... in schools proposed by Senate,Agriculture Committee Chairman Tom ... US applauds Senators Harkin and Murkowski for championing ...
... Consumers Union finds up to $1,900 annual increases in ... during Nov. 15 open,enrollment period, WASHINGTON, Nov. 9 ... shopping during open enrollment could be,in for a nasty ... year for,premiums and five commonly used prescriptions -- the ...
Cached Medicine News:Health News:HIV drug resistance risk in mothers reduced by combination of common drugs 2Health News:Close to Barefoot Best for Arthritic Knees 2Health News:Close to Barefoot Best for Arthritic Knees 3Health News:Close to Barefoot Best for Arthritic Knees 4Health News:Chicago's Premier Sports and Fitness Auction is Back! 2Health News:Babies Driving Robots at University 2Health News:Babies Driving Robots at University 3Health News:Babies Driving Robots at University 4Health News:Babies Driving Robots at University 5Health News:Babies Driving Robots at University 6Health News:Mars US Supports Harkin/Murkowski Amendment to Update Nutrition Standards for Foods Sold in Schools 2Health News:Cha-Ching! Seniors Enrolled in Medicare Prescription Drug Plans Might Be in for Sticker Shock Next Year 2Health News:Cha-Ching! Seniors Enrolled in Medicare Prescription Drug Plans Might Be in for Sticker Shock Next Year 3Health News:Cha-Ching! Seniors Enrolled in Medicare Prescription Drug Plans Might Be in for Sticker Shock Next Year 4
(Date:2/27/2015)... /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: ... results for its first quarter ended December 31, 2014. ... 31, 2014, revenue was $1,336,685. Operating expenses were $1,063,393. ... per share.  Covalon,s President and CEO, ... with the significant progress we have made over the ...
(Date:2/27/2015)... SOUTH PLAINFIELD, N.J., Feb. 27, 2015  PTC Therapeutics, ... corporate update and reported financial results for the fourth ... "2014 was a transformative year for PTC. ... on delivering and developing RNA-targeted therapies in the rare ... Officer, PTC Therapeutics, Inc. "We are proud to bring ...
(Date:2/27/2015)... SAN DIEGO , Feb. 27, 2015 /PRNewswire/ ... three-dimensional biology company focused on delivering breakthrough 3D ... , President and Chief Executive Officer, will present ... "We invite you to join us for ... to provide updates on our commercial launch of ...
Breaking Medicine Technology:Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 2Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 4
... RGEN ) today announced positive results from a Phase ... in patients with bipolar,disorder. This was a multi-center study ... twice a day for six-weeks. Patients in the,RG2417 and ... baseline,with the exception of mania for which the RG2417 ...
... and Major Secondary Endpoints in the Largest ... Date in Psoriatic Arthritis, BOSTON, Nov. 7 ... (SC) injections of golimumab (CNTO 148),experienced significant and ... the disease, according to findings from the largest ...
Cached Medicine Technology:Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder 2Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder 3Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder 4Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis 2Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis 3Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis 4Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis 5Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis 6Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis 7Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis 8
Used for stone manipulation and removal in the renal pelvis under direct vision. Supplied sterile in peel-open packages. Intended for one-time use....
... is designed to provide rapid atraumatic stone ... NCircle combines traditional surgical instrument design with ... technology. The small, flexible wire design ... surgeon to remove larger stones or stone ...
... Used for temporary internal drainage ... bladder. Supplied sterile in peel-open packages. ... evaluation is advised; C-Flex® and Sof-Flex® ... than six (6) months; silicone stents ...
... ACMI™ Classic Double Pigtail Ureteral Stents ... design that maximizes migration. They also ... versatility and cost savings. Each Classic ... one Classic Double PigTail Ureteral Stent ...
Medicine Products: